Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis

Objective To investigate correlations between biomarkers of bone remodelling and extracellular matrix turnover with baseline disease activity and treatment response in patients with early rheumatoid arthritis (RA).Methods Assessing Very Early Rheumatoid arthritis Treatment-2 (AVERT-2; NCT02504268) i...

Full description

Bibliographic Details
Main Authors: Roy Fleischmann, Yoshiya Tanaka, Paul Emery, Vivian P Bykerk, Sean E Connolly, Chun Wu, Robert Wong, Jinqi Liu, Peter Schafer, Yanhua Hu, Anne-Christine Bay-Jensen, Signe Holm Nielsen, Thomas WJ Huizinga
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002683.full

Internet

https://rmdopen.bmj.com/content/8/2/e002683.full

Similar Items